Patents by Inventor Melissa A. Ashlock

Melissa A. Ashlock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160369259
    Abstract: The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.
    Type: Application
    Filed: December 23, 2015
    Publication date: December 22, 2016
    Inventors: Kyle P. Chiang, Elisabeth Gardiner, Ching-Fun Lau, Wing-Sze Lo, Jeffrey Greve, Melissa Ashlock, John D. Mendlein
  • Patent number: 9273302
    Abstract: The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: March 1, 2016
    Assignees: aTyr Pharma, Inc., Pangu BioPharma Limited
    Inventors: Kyle P. Chiang, Elisabeth Gardiner, Ching-Fun Lau, Wing-Sze Lo, Jeffrey Greve, Melissa Ashlock, John D. Mendlein
  • Publication number: 20150093799
    Abstract: The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.
    Type: Application
    Filed: August 7, 2014
    Publication date: April 2, 2015
    Inventors: Kyle P. Chiang, Elisabeth Gardiner, Ching-Fun Lau, Wing-Sze Lo, Jeffrey Greve, Melissa Ashlock, John D. Mendlein
  • Patent number: 8835387
    Abstract: The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: September 16, 2014
    Assignees: aTyr Pharma, Inc., Pangu Biopharma Limited
    Inventors: Kyle P. Chiang, Elisabeth Gardiner, Ching-Fun Lau, Wing-Sze Lo, Jeffrey Greve, Melissa Ashlock, John D. Mendlein
  • Publication number: 20130344096
    Abstract: The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.
    Type: Application
    Filed: February 15, 2013
    Publication date: December 26, 2013
    Applicants: PANGU BIOPHARMA LIMITED, ATYR PHARMA, INC.
    Inventors: Kyle P. Chiang, Elisabeth Gardiner, Ching-Fun Lau, Wing-Sze Lo, Jeffrey Greve, Melissa Ashlock, John D. Mendlein
  • Patent number: 7045675
    Abstract: A gene for type C Niemann-Pick disease (NP-C) is disclosed, along with the amino acid sequence of the encoded peptide. Applications which are made possible by the present invention include detection of NP-C carriers and diagnosis of NP-C sufferers. The murine ortholog of the human gene is also disclosed.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: May 16, 2006
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Eugene D Carstea, Danilo A. Tagle, Jill A. Morris, Peter G. Pentchev, William J. Pavan, Melissa A. Ashlock, Stacie K. Loftus, Jessie Gu
  • Publication number: 20030092038
    Abstract: A gene for type C Niemann-Pick disease (NP-C) is disclosed, along with the amino acid sequence of the encoded peptide. Applications which are made possible by the present invention include detection of NP-C carriers and diagnosis of NP-C sufferers. The murine ortholog of the human gene is also disclosed.
    Type: Application
    Filed: July 29, 2002
    Publication date: May 15, 2003
    Applicant: The Govt. of the USA, as represented by the Secretary of the Dept. of Health & Human Services
    Inventors: Eugene D. Carstea, Danilo A. Tagle, Jill A. Morris, Peter G. Pentchev, William J. Pavan, Melissa A. Ashlock, Stacie K. Loftus, Jessie Gu
  • Patent number: 6426198
    Abstract: A gene for type C Niemann-Pick disease (NP-C) is disclosed, along with the amino acid sequence of the encoded peptide. Applications which are made possible by the present invention include detection of NP-C carriers and diagnosis of NP-C sufferers. The murine ortholog of the human gene is also disclosed.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: July 30, 2002
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Eugene D. Carstea, Danilo A. Tagle, Jill A. Morris, Peter G. Pentchev, William J. Pavan, Melissa A. Ashlock, Stacie K. Loftus, Jessie Gu